ConforMIS Reports First Quarter 2017 Financial Results
May 10, 2017 20:07 pm UTC| Business
BILLERICA, Mass., May 10, 2017 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement...
UPDATE -- Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
May 10, 2017 20:07 pm UTC| Business
CAMBRIDGE, Mass., May 10, 2017 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its...
ConforMIS Reports First Quarter 2017 Financial Results
May 10, 2017 20:07 pm UTC| Business
BILLERICA, Mass., May 10, 2017 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement...
miRagen Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 10, 2017 20:06 pm UTC| Business
MRG-106 granted orphan-drug status for the treatment of mycosis fungoides by U.S. Food and Drug Administration (FDA)miRagen’s collaboration with Servier extended with the objective to start testing MRG-110 in humans within...
miRagen Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 10, 2017 20:06 pm UTC| Business
MRG-106 granted orphan-drug status for the treatment of mycosis fungoides by U.S. Food and Drug Administration (FDA)miRagen’s collaboration with Servier extended with the objective to start testing MRG-110 in humans within...
REGENXBIO to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
May 10, 2017 20:06 pm UTC| Business
ROCKVILLE, Md., May 10, 2017 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®...
REGENXBIO to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
May 10, 2017 20:06 pm UTC| Business
ROCKVILLE, Md., May 10, 2017 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®...